Andrx Pharma hit with 9-item 483 citing QC violations and control procedures.(HUMAN DRUGS/BIOLOGICS): An article from: Inspection Monitor

This digital document is an article from Inspection Monitor, published by Thomson Gale on August 1, 2006. The length of the article is 1112 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Andrx Pharma hit with 9-item 483 citing QC violations and control procedures.(HUMAN DRUGS/BIOLOGICS)
Author: Gale Reference Team
Publication:Inspection Monitor (Newsletter)
Date: August 1, 2006
Publisher: Thomson Gale
Volume: 11 Issue: 8 Page: 6

Distributed by Thomson Gale